Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. M.G.G. (Marieke) Sturkenboom

Publicaties

Fluoroquinolones and rifampin combination in the backdrop of heteroresistant tuberculosis

Safety, Efficacy and Pharmacokinetics of daily optimised doses of Rifampicin for the Treatment of Tuberculosis: A Systematic Review and Bayesian Network Meta-Analysis

The effect of acetylcysteine on the prothrombin time and international normalized ratio: a narrative review

Measurement of isoniazid in tuberculosis patients using finger sweat with creatinine normalisation: A controlled administration study

Reply to 'Therapeutic drug monitoring for isoniazid and rifampicin exposure'

Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial

Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations

Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trials

Clinical standards for the management of adverse effects during treatment for TB

Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment